John Treanor
Concepts (540)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Influenza Vaccines | 62 | 1990 | 70 |
Why?
| Influenza, Human | 54 | 1987 | 94 |
Why?
| Influenza A virus | 40 | 1989 | 63 |
Why?
| Antibodies, Viral | 50 | 1986 | 104 |
Why?
| Vaccination | 27 | 1994 | 92 |
Why?
| Influenza A Virus, H5N1 Subtype | 11 | 2006 | 14 |
Why?
| Influenza A Virus, H1N1 Subtype | 13 | 1990 | 27 |
Why?
| Hemagglutinin Glycoproteins, Influenza Virus | 14 | 1993 | 17 |
Why?
| Influenza B virus | 17 | 1993 | 16 |
Why?
| Vaccines, Synthetic | 16 | 1991 | 30 |
Why?
| Double-Blind Method | 42 | 1990 | 274 |
Why?
| Adult | 77 | 1986 | 1317 |
Why?
| Thimerosal | 4 | 2002 | 7 |
Why?
| Disease Outbreaks | 8 | 1990 | 61 |
Why?
| Antigens, Viral | 14 | 1986 | 53 |
Why?
| Preservatives, Pharmaceutical | 3 | 2002 | 6 |
Why?
| Humans | 137 | 1986 | 1856 |
Why?
| Mercury | 3 | 2002 | 25 |
Why?
| Adolescent | 43 | 1986 | 891 |
Why?
| Antiviral Agents | 11 | 1994 | 91 |
Why?
| Viral Vaccines | 7 | 1993 | 35 |
Why?
| Gastroenteritis | 13 | 1986 | 20 |
Why?
| Middle Aged | 51 | 1986 | 1161 |
Why?
| Hemagglutinins, Viral | 4 | 1993 | 11 |
Why?
| Antibodies, Bacterial | 10 | 1997 | 50 |
Why?
| Hemagglutination Inhibition Tests | 19 | 1990 | 28 |
Why?
| Virus Diseases | 10 | 1986 | 50 |
Why?
| Female | 64 | 1988 | 1643 |
Why?
| Orthomyxoviridae | 7 | 1998 | 34 |
Why?
| Adjuvants, Immunologic | 10 | 1997 | 73 |
Why?
| Vaccines, Inactivated | 14 | 1990 | 15 |
Why?
| Male | 58 | 1992 | 1553 |
Why?
| Vaccines | 2 | 2002 | 33 |
Why?
| Neuraminidase | 7 | 1996 | 12 |
Why?
| Vaccines, Attenuated | 21 | 1990 | 22 |
Why?
| Respiratory Syncytial Virus Infections | 4 | 1999 | 35 |
Why?
| Respiratory Tract Infections | 4 | 1992 | 57 |
Why?
| Flagellin | 2 | 2010 | 6 |
Why?
| Rotavirus | 5 | 1993 | 13 |
Why?
| Rotavirus Infections | 5 | 1993 | 12 |
Why?
| Hepatitis B Vaccines | 3 | 1999 | 17 |
Why?
| Vaccinia | 3 | 2004 | 7 |
Why?
| Antibody Formation | 4 | 2004 | 89 |
Why?
| Norwalk virus | 10 | 1986 | 3 |
Why?
| Recombinant Proteins | 9 | 1993 | 290 |
Why?
| Plasmodium falciparum | 2 | 2008 | 9 |
Why?
| Streptococcus pneumoniae | 4 | 1997 | 38 |
Why?
| Whooping Cough | 5 | 1997 | 14 |
Why?
| Influenza A Virus, H3N2 Subtype | 6 | 1990 | 21 |
Why?
| Smallpox Vaccine | 3 | 2002 | 7 |
Why?
| Polysaccharides, Bacterial | 5 | 1997 | 33 |
Why?
| Injections, Intramuscular | 8 | 1990 | 43 |
Why?
| Enzyme Inhibitors | 6 | 1996 | 216 |
Why?
| Brucella Vaccine | 1 | 2010 | 1 |
Why?
| Brucellosis | 1 | 2010 | 1 |
Why?
| Immunization, Passive | 2 | 1990 | 39 |
Why?
| Aged | 28 | 1992 | 988 |
Why?
| Post-Exposure Prophylaxis | 1 | 2009 | 2 |
Why?
| Bacterial Vaccines | 4 | 1997 | 27 |
Why?
| Chemoprevention | 1 | 2009 | 12 |
Why?
| Administration, Intranasal | 15 | 1987 | 25 |
Why?
| Pneumococcal Vaccines | 4 | 1998 | 17 |
Why?
| Malaria Vaccines | 2 | 2008 | 2 |
Why?
| Respiratory Syncytial Virus, Human | 3 | 2003 | 15 |
Why?
| Infant | 19 | 1986 | 464 |
Why?
| Animals | 38 | 1988 | 1031 |
Why?
| Smallpox | 2 | 2002 | 8 |
Why?
| Malaria, Falciparum | 1 | 2008 | 2 |
Why?
| Stress, Psychological | 4 | 2002 | 117 |
Why?
| Antigens, Protozoan | 1 | 2008 | 6 |
Why?
| Capsid | 7 | 1989 | 14 |
Why?
| Pneumococcal Infections | 3 | 1997 | 31 |
Why?
| Immunity, Mucosal | 3 | 2000 | 16 |
Why?
| Enzyme-Linked Immunosorbent Assay | 10 | 1986 | 224 |
Why?
| Immunoglobulin G | 13 | 1986 | 191 |
Why?
| Young Adult | 10 | 2008 | 380 |
Why?
| Dose-Response Relationship, Immunologic | 7 | 2001 | 37 |
Why?
| Poultry | 1 | 2007 | 3 |
Why?
| Influenza in Birds | 1 | 2007 | 5 |
Why?
| Affect | 2 | 2004 | 55 |
Why?
| Child, Preschool | 18 | 1986 | 554 |
Why?
| Viral Core Proteins | 3 | 1989 | 14 |
Why?
| Infant, Newborn | 3 | 1995 | 389 |
Why?
| Sick Role | 1 | 2006 | 26 |
Why?
| Pneumonia, Viral | 1 | 2006 | 17 |
Why?
| Aluminum Hydroxide | 4 | 2008 | 9 |
Why?
| Social Support | 2 | 2004 | 111 |
Why?
| Placebos | 4 | 2002 | 110 |
Why?
| Drug Approval | 1 | 2005 | 15 |
Why?
| Cold Temperature | 13 | 1990 | 59 |
Why?
| Aged, 80 and over | 13 | 1992 | 599 |
Why?
| Bordetella pertussis | 4 | 2004 | 9 |
Why?
| Loneliness | 1 | 2005 | 9 |
Why?
| Universities | 1 | 2005 | 28 |
Why?
| Immunoglobulin A | 8 | 1990 | 39 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2005 | 61 |
Why?
| United States | 8 | 1990 | 604 |
Why?
| Prospective Studies | 15 | 1992 | 545 |
Why?
| Students | 1 | 2005 | 38 |
Why?
| Baculoviridae | 6 | 1995 | 23 |
Why?
| Antigenic Variation | 1 | 2004 | 10 |
Why?
| Interleukin-6 | 1 | 2006 | 145 |
Why?
| Communicable Disease Control | 1 | 2004 | 20 |
Why?
| Rotavirus Vaccines | 3 | 1995 | 9 |
Why?
| Immunization, Secondary | 5 | 1997 | 31 |
Why?
| Half-Life | 3 | 2002 | 69 |
Why?
| Child | 14 | 1986 | 749 |
Why?
| Neutralization Tests | 5 | 1996 | 37 |
Why?
| Genes, Viral | 5 | 1989 | 37 |
Why?
| Common Cold | 3 | 1999 | 8 |
Why?
| Pertussis Vaccine | 3 | 2004 | 8 |
Why?
| Corynebacterium diphtheriae | 1 | 2001 | 5 |
Why?
| Bison | 2 | 2010 | 2 |
Why?
| Viral Matrix Proteins | 2 | 1990 | 12 |
Why?
| Virus Replication | 8 | 1989 | 90 |
Why?
| Vaccines, DNA | 3 | 2007 | 16 |
Why?
| Acetamides | 1 | 2000 | 20 |
Why?
| Vaccines, Conjugate | 3 | 1997 | 14 |
Why?
| Hemagglutinins | 3 | 2005 | 12 |
Why?
| Immunity, Cellular | 3 | 2005 | 85 |
Why?
| Caliciviridae Infections | 3 | 1995 | 2 |
Why?
| Drosophila Proteins | 2 | 1996 | 23 |
Why?
| Nerve Growth Factors | 2 | 1996 | 43 |
Why?
| Sialic Acids | 4 | 1996 | 17 |
Why?
| B-Lymphocytes | 3 | 2000 | 134 |
Why?
| Bacterial Proteins | 2 | 1997 | 99 |
Why?
| Oligodeoxyribonucleotides | 2 | 2008 | 86 |
Why?
| Feces | 6 | 1986 | 43 |
Why?
| Antibodies, Monoclonal | 4 | 1988 | 241 |
Why?
| Vaccinia virus | 2 | 2006 | 22 |
Why?
| Caliciviridae | 6 | 1986 | 1 |
Why?
| RNA, Viral | 5 | 1994 | 91 |
Why?
| Immunization Schedule | 3 | 2001 | 25 |
Why?
| Oseltamivir | 3 | 1999 | 8 |
Why?
| Oligosaccharides | 1 | 1997 | 19 |
Why?
| Models, Statistical | 2 | 2006 | 114 |
Why?
| Nerve Tissue Proteins | 2 | 1996 | 128 |
Why?
| Glycosylphosphatidylinositols | 1 | 1996 | 8 |
Why?
| Receptor Protein-Tyrosine Kinases | 2 | 1996 | 40 |
Why?
| HIV Infections | 4 | 1998 | 136 |
Why?
| Cost of Illness | 1 | 1997 | 54 |
Why?
| Antigens, Bacterial | 4 | 1998 | 44 |
Why?
| Zanamivir | 5 | 1996 | 9 |
Why?
| Day Care | 1 | 1995 | 11 |
Why?
| Amino Acid Sequence | 8 | 1989 | 319 |
Why?
| Immunologic Memory | 4 | 1999 | 51 |
Why?
| Proto-Oncogene Proteins | 2 | 1996 | 113 |
Why?
| Rhinovirus | 3 | 1995 | 11 |
Why?
| Safety | 2 | 2000 | 80 |
Why?
| Frail Elderly | 1 | 1995 | 29 |
Why?
| Cross Reactions | 6 | 1990 | 63 |
Why?
| Immunoenzyme Techniques | 3 | 1988 | 125 |
Why?
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 1993 | 5 |
Why?
| Cryptococcosis | 1 | 1993 | 8 |
Why?
| Wyoming | 2 | 2010 | 1 |
Why?
| Cryptococcus neoformans | 1 | 1993 | 7 |
Why?
| Aging | 3 | 1994 | 275 |
Why?
| Peritonitis | 1 | 1993 | 28 |
Why?
| Viral Proteins | 2 | 1986 | 71 |
Why?
| Nasal Lavage Fluid | 5 | 1994 | 2 |
Why?
| Point Mutation | 1 | 1994 | 122 |
Why?
| Viral Nonstructural Proteins | 3 | 1989 | 8 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 1999 | 210 |
Why?
| Antibody-Producing Cells | 2 | 2010 | 20 |
Why?
| Cytokines | 3 | 1999 | 207 |
Why?
| DNA, Viral | 3 | 1989 | 98 |
Why?
| Molecular Sequence Data | 9 | 1989 | 404 |
Why?
| Nasopharynx | 2 | 1989 | 27 |
Why?
| Mice | 13 | 1988 | 623 |
Why?
| Statistics, Nonparametric | 2 | 2000 | 141 |
Why?
| Interferon-gamma | 4 | 1999 | 133 |
Why?
| CD8-Positive T-Lymphocytes | 3 | 2000 | 91 |
Why?
| Guanidines | 5 | 1996 | 26 |
Why?
| Serotyping | 4 | 1995 | 26 |
Why?
| Reassortant Viruses | 3 | 1996 | 3 |
Why?
| Mass Vaccination | 2 | 2004 | 13 |
Why?
| Seasons | 2 | 1995 | 64 |
Why?
| Biosensing Techniques | 2 | 1998 | 12 |
Why?
| Cricetinae | 5 | 1991 | 130 |
Why?
| Nucleoproteins | 1 | 1991 | 10 |
Why?
| Toll-Like Receptor 5 | 1 | 2011 | 5 |
Why?
| Dose-Response Relationship, Drug | 5 | 1999 | 431 |
Why?
| Cattle | 5 | 1993 | 176 |
Why?
| Suppression, Genetic | 1 | 1991 | 19 |
Why?
| Animal Migration | 1 | 2011 | 1 |
Why?
| Base Sequence | 7 | 1989 | 371 |
Why?
| Nasal Mucosa | 3 | 1987 | 22 |
Why?
| Pandemics | 1 | 2011 | 6 |
Why?
| Nursing Homes | 4 | 1992 | 55 |
Why?
| Computer Simulation | 2 | 2009 | 134 |
Why?
| Receptors, Lymphocyte Homing | 1 | 2010 | 10 |
Why?
| Virus Shedding | 4 | 1996 | 8 |
Why?
| Orthomyxoviridae Infections | 2 | 1994 | 29 |
Why?
| Cell Line | 7 | 1991 | 375 |
Why?
| Microarray Analysis | 1 | 2010 | 24 |
Why?
| Abortion, Veterinary | 1 | 2010 | 2 |
Why?
| Spodoptera | 2 | 1995 | 12 |
Why?
| Escherichia coli | 2 | 2010 | 143 |
Why?
| Vaccines, Subunit | 1 | 2010 | 10 |
Why?
| Drug Toxicity | 1 | 2010 | 16 |
Why?
| Membrane Proteins | 2 | 2000 | 233 |
Why?
| Kinetics | 2 | 2001 | 349 |
Why?
| Developed Countries | 1 | 2009 | 9 |
Why?
| Amantadine | 1 | 2009 | 19 |
Why?
| Immunity, Humoral | 1 | 2009 | 12 |
Why?
| Lymphocyte Subsets | 1 | 2009 | 26 |
Why?
| Drug Administration Schedule | 4 | 2000 | 191 |
Why?
| Bacillus anthracis | 1 | 2009 | 5 |
Why?
| Anthrax Vaccines | 1 | 2009 | 2 |
Why?
| Anthrax | 1 | 2009 | 3 |
Why?
| C-Reactive Protein | 1 | 2010 | 54 |
Why?
| Blood | 1 | 2009 | 67 |
Why?
| Developing Countries | 1 | 2009 | 28 |
Why?
| Case-Control Studies | 2 | 2001 | 283 |
Why?
| Cyclooxygenase 2 Inhibitors | 1 | 2009 | 45 |
Why?
| Malaria | 1 | 2009 | 10 |
Why?
| Infant, Low Birth Weight | 1 | 2009 | 31 |
Why?
| Gene Expression | 3 | 1995 | 291 |
Why?
| Toll-Like Receptor 9 | 1 | 2009 | 14 |
Why?
| Virion | 2 | 1986 | 24 |
Why?
| Mutation | 5 | 1991 | 340 |
Why?
| Population Surveillance | 1 | 2009 | 70 |
Why?
| Saliva | 3 | 2002 | 61 |
Why?
| Skin Diseases | 1 | 2010 | 69 |
Why?
| Protozoan Proteins | 1 | 2008 | 13 |
Why?
| Phagocytosis | 1 | 2008 | 51 |
Why?
| B-Lymphocyte Subsets | 1 | 2009 | 33 |
Why?
| Ethylmercury Compounds | 1 | 2008 | 4 |
Why?
| Disease Susceptibility | 2 | 2004 | 61 |
Why?
| Drug Resistance, Viral | 2 | 2003 | 17 |
Why?
| BCG Vaccine | 1 | 2008 | 22 |
Why?
| Cyclooxygenase 2 | 1 | 2009 | 77 |
Why?
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2008 | 18 |
Why?
| Histocompatibility Antigens Class II | 1 | 2009 | 50 |
Why?
| Culture | 1 | 2008 | 41 |
Why?
| Zoonoses | 1 | 2007 | 8 |
Why?
| Immunodiffusion | 1 | 2007 | 30 |
Why?
| Models, Biological | 2 | 2009 | 410 |
Why?
| Interferon Type I | 1 | 1987 | 22 |
Why?
| Infant, Premature | 1 | 2009 | 70 |
Why?
| Leukocytes, Mononuclear | 3 | 1999 | 67 |
Why?
| Squalene | 1 | 2006 | 3 |
Why?
| Polysorbates | 1 | 2006 | 4 |
Why?
| Alum Compounds | 1 | 2006 | 5 |
Why?
| Health Priorities | 1 | 2006 | 11 |
Why?
| Cloning, Molecular | 4 | 1991 | 183 |
Why?
| Acute Disease | 3 | 1992 | 271 |
Why?
| Cell Culture Techniques | 2 | 2002 | 74 |
Why?
| Hepatitis | 1 | 2006 | 13 |
Why?
| Socioeconomic Factors | 1 | 2008 | 144 |
Why?
| Maximum Tolerated Dose | 1 | 2006 | 18 |
Why?
| Hydrocortisone | 2 | 2002 | 65 |
Why?
| Interleukin-1beta | 1 | 2006 | 36 |
Why?
| Kupffer Cells | 1 | 2006 | 11 |
Why?
| Emotions | 1 | 2006 | 58 |
Why?
| Interferons | 1 | 2006 | 39 |
Why?
| Immunity, Innate | 1 | 2006 | 60 |
Why?
| Aspergillus niger | 1 | 2005 | 4 |
Why?
| Aspergillosis | 1 | 2005 | 18 |
Why?
| Age Factors | 4 | 1997 | 480 |
Why?
| Tetanus Toxoid | 2 | 1999 | 27 |
Why?
| Neisseria meningitidis | 1 | 2005 | 11 |
Why?
| Cost-Benefit Analysis | 1 | 2006 | 118 |
Why?
| Treatment Outcome | 6 | 1997 | 661 |
Why?
| Pennsylvania | 1 | 2005 | 16 |
Why?
| Virulence | 1 | 2006 | 48 |
Why?
| Norovirus | 1 | 2005 | 3 |
Why?
| Respiratory Insufficiency | 1 | 2005 | 40 |
Why?
| New York | 3 | 1995 | 422 |
Why?
| Sleep | 1 | 2005 | 31 |
Why?
| Cyclopentanes | 1 | 2005 | 6 |
Why?
| Chemistry, Pharmaceutical | 1 | 2004 | 17 |
Why?
| Time Factors | 4 | 1997 | 896 |
Why?
| Incidence | 2 | 2004 | 336 |
Why?
| Cross-Linking Reagents | 3 | 1996 | 38 |
Why?
| Genetic Drift | 1 | 2004 | 1 |
Why?
| Monitoring, Ambulatory | 1 | 2004 | 15 |
Why?
| Models, Immunological | 1 | 2004 | 40 |
Why?
| Vaccines, Combined | 2 | 1999 | 9 |
Why?
| Communicable Diseases | 1 | 2004 | 22 |
Why?
| Follow-Up Studies | 1 | 2009 | 553 |
Why?
| Immunocompromised Host | 2 | 1999 | 70 |
Why?
| Sleep Disorders | 1 | 2004 | 32 |
Why?
| Geriatric Assessment | 1 | 2004 | 63 |
Why?
| Circadian Rhythm | 1 | 2004 | 50 |
Why?
| Cohort Studies | 2 | 2002 | 332 |
Why?
| Sex Distribution | 1 | 2004 | 101 |
Why?
| Nose | 3 | 1997 | 31 |
Why?
| Age Distribution | 1 | 2004 | 127 |
Why?
| Risk Factors | 2 | 2006 | 555 |
Why?
| Patient Selection | 1 | 2004 | 155 |
Why?
| Immunoglobulin A, Secretory | 3 | 1990 | 11 |
Why?
| Variola virus | 1 | 2002 | 2 |
Why?
| Diarrhea | 2 | 1988 | 41 |
Why?
| Clinical Trials as Topic | 1 | 2006 | 251 |
Why?
| Hair | 1 | 2002 | 23 |
Why?
| Homes for the Aged | 2 | 1992 | 25 |
Why?
| Immune System | 1 | 2002 | 43 |
Why?
| Caregivers | 1 | 2002 | 50 |
Why?
| Fever | 4 | 1998 | 65 |
Why?
| Receptors, Drug | 1 | 2001 | 16 |
Why?
| Single-Blind Method | 3 | 2002 | 86 |
Why?
| Adaptation, Physiological | 4 | 1992 | 74 |
Why?
| Saimiri | 2 | 1989 | 22 |
Why?
| Viral Plaque Assay | 2 | 1994 | 18 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 243 |
Why?
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 2 | 1996 | 1 |
Why?
| Proto-Oncogene Proteins c-ret | 2 | 1996 | 4 |
Why?
| Glial Cell Line-Derived Neurotrophic Factor | 2 | 1996 | 6 |
Why?
| Mice, Inbred BALB C | 3 | 1988 | 176 |
Why?
| CHO Cells | 2 | 1996 | 65 |
Why?
| Coronavirus Infections | 1 | 1999 | 10 |
Why?
| CD4 Lymphocyte Count | 3 | 1998 | 50 |
Why?
| Epitopes | 2 | 1990 | 86 |
Why?
| Amyloid beta-Protein Precursor | 1 | 1999 | 15 |
Why?
| Aspartic Acid Endopeptidases | 1 | 1999 | 16 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1999 | 53 |
Why?
| Paramyxoviridae Infections | 1 | 1999 | 12 |
Why?
| Amyloid beta-Peptides | 1 | 1999 | 24 |
Why?
| Sequence Homology, Nucleic Acid | 2 | 1989 | 88 |
Why?
| Immunoglobulin M | 2 | 1993 | 81 |
Why?
| Pyrans | 4 | 1996 | 11 |
Why?
| Risk Assessment | 1 | 2004 | 324 |
Why?
| Amines | 1 | 1999 | 39 |
Why?
| Hemagglutination Tests | 1 | 1998 | 13 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2000 | 67 |
Why?
| Bacterial Capsules | 1 | 1998 | 16 |
Why?
| Recombinant Fusion Proteins | 3 | 1999 | 189 |
Why?
| Models, Theoretical | 2 | 2009 | 124 |
Why?
| Ligands | 3 | 2000 | 116 |
Why?
| Electrophoresis, Polyacrylamide Gel | 2 | 1994 | 167 |
Why?
| Cells, Cultured | 3 | 1996 | 447 |
Why?
| AIDS Vaccines | 1 | 1999 | 18 |
Why?
| Polymerase Chain Reaction | 2 | 1991 | 279 |
Why?
| CD4-Positive T-Lymphocytes | 3 | 2000 | 113 |
Why?
| Ear, Middle | 1 | 1997 | 11 |
Why?
| Species Specificity | 2 | 1986 | 186 |
Why?
| Recombination, Genetic | 3 | 1991 | 78 |
Why?
| Antibody Specificity | 2 | 1993 | 71 |
Why?
| Tumor Cells, Cultured | 2 | 1996 | 233 |
Why?
| Dogs | 2 | 1994 | 159 |
Why?
| Phenotype | 3 | 1992 | 303 |
Why?
| Child Care | 1 | 1997 | 12 |
Why?
| Absenteeism | 1 | 1997 | 26 |
Why?
| Chronic Disease | 2 | 1994 | 267 |
Why?
| Clinical Laboratory Techniques | 1 | 1997 | 31 |
Why?
| Viruses, Unclassified | 2 | 1986 | 2 |
Why?
| Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1996 | 10 |
Why?
| Phosphorylation | 2 | 1996 | 224 |
Why?
| Insects | 1 | 1996 | 11 |
Why?
| Phosphoric Diester Hydrolases | 1 | 1996 | 29 |
Why?
| Mesencephalon | 1 | 1996 | 22 |
Why?
| Medical Records | 1 | 1997 | 104 |
Why?
| Cricetulus | 1 | 1996 | 39 |
Why?
| Office Visits | 1 | 1997 | 50 |
Why?
| Tissue Distribution | 1 | 1996 | 124 |
Why?
| Alzheimer Disease | 1 | 1999 | 71 |
Why?
| Severity of Illness Index | 1 | 2000 | 358 |
Why?
| Predictive Value of Tests | 2 | 2006 | 321 |
Why?
| Tyrosine | 1 | 1996 | 71 |
Why?
| Serologic Tests | 2 | 2000 | 24 |
Why?
| Motor Neurons | 1 | 1996 | 45 |
Why?
| Lymphocyte Activation | 3 | 1999 | 137 |
Why?
| Embryo, Mammalian | 1 | 1996 | 99 |
Why?
| Chlamydophila pneumoniae | 1 | 1995 | 9 |
Why?
| T-Lymphocytes | 1 | 1999 | 182 |
Why?
| Enterovirus | 1 | 1995 | 11 |
Why?
| RNA Replicase | 1 | 1994 | 11 |
Why?
| Mesocricetus | 1 | 1994 | 17 |
Why?
| Allied Health Personnel | 1 | 1995 | 16 |
Why?
| Aspartic Acid | 1 | 1994 | 37 |
Why?
| Confidence Intervals | 1 | 1995 | 104 |
Why?
| Chick Embryo | 1 | 1994 | 62 |
Why?
| Thiadiazoles | 1 | 1994 | 8 |
Why?
| Serine | 1 | 1994 | 62 |
Why?
| Nitriles | 1 | 1994 | 27 |
Why?
| Emergency Service, Hospital | 1 | 1997 | 94 |
Why?
| Multicenter Studies as Topic | 2 | 1996 | 70 |
Why?
| Mice, Inbred Strains | 1 | 1994 | 118 |
Why?
| Temperature | 1 | 1994 | 137 |
Why?
| Amphotericin B | 1 | 1993 | 20 |
Why?
| Hospitalization | 1 | 1997 | 169 |
Why?
| HN Protein | 1 | 1993 | 10 |
Why?
| Infusions, Intravenous | 1 | 1993 | 87 |
Why?
| Influenza A Virus, H2N2 Subtype | 1 | 1992 | 3 |
Why?
| Chickens | 1 | 1993 | 81 |
Why?
| Lung | 2 | 1990 | 232 |
Why?
| Mice, Inbred C57BL | 2 | 2006 | 318 |
Why?
| Serial Passage | 1 | 1991 | 2 |
Why?
| Pan troglodytes | 1 | 1991 | 13 |
Why?
| Nucleocapsid Proteins | 1 | 1991 | 6 |
Why?
| Questionnaires | 1 | 1997 | 360 |
Why?
| Rats | 2 | 1996 | 530 |
Why?
| Administration, Oral | 2 | 1999 | 170 |
Why?
| Brucellosis, Bovine | 1 | 2011 | 1 |
Why?
| Ecosystem | 1 | 2011 | 7 |
Why?
| Disease Transmission, Infectious | 1 | 2011 | 12 |
Why?
| Trees | 1 | 2011 | 4 |
Why?
| Population Dynamics | 1 | 2011 | 14 |
Why?
| Viral Load | 2 | 1999 | 53 |
Why?
| Chitosan | 1 | 2010 | 4 |
Why?
| Environment | 1 | 2011 | 43 |
Why?
| Nausea | 2 | 1999 | 34 |
Why?
| Lipid A | 1 | 2010 | 7 |
Why?
| Bayes Theorem | 1 | 2011 | 24 |
Why?
| Kidney | 1 | 1994 | 223 |
Why?
| Mucous Membrane | 1 | 2010 | 37 |
Why?
| Environmental Monitoring | 1 | 2011 | 28 |
Why?
| Nasal Cavity | 1 | 1990 | 12 |
Why?
| Lymphoid Tissue | 1 | 2010 | 34 |
Why?
| Retrospective Studies | 1 | 1997 | 653 |
Why?
| Protein Conformation | 1 | 1991 | 123 |
Why?
| Hong Kong | 1 | 2009 | 11 |
Why?
| Gene Library | 2 | 1999 | 50 |
Why?
| Texas | 1 | 2009 | 21 |
Why?
| Random Allocation | 1 | 1990 | 160 |
Why?
| Macaca fascicularis | 1 | 2009 | 36 |
Why?
| Immunodominant Epitopes | 1 | 2009 | 14 |
Why?
| Epitopes, B-Lymphocyte | 1 | 2009 | 6 |
Why?
| Clinical Trials, Phase I as Topic | 1 | 2009 | 13 |
Why?
| Drug Evaluation, Preclinical | 1 | 2009 | 65 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 2009 | 38 |
Why?
| Bacterial Toxins | 1 | 2009 | 24 |
Why?
| CpG Islands | 1 | 2009 | 26 |
Why?
| RNA-Directed DNA Polymerase | 1 | 1989 | 28 |
Why?
| Trachea | 1 | 1989 | 50 |
Why?
| HIV-1 | 3 | 1998 | 93 |
Why?
| Alleles | 1 | 1989 | 108 |
Why?
| Binding, Competitive | 1 | 1988 | 109 |
Why?
| Sequence Alignment | 2 | 1997 | 114 |
Why?
| Rabbits | 1 | 2009 | 252 |
Why?
| Social Class | 1 | 2008 | 46 |
Why?
| Ultracentrifugation | 1 | 2007 | 17 |
Why?
| Picornaviridae Infections | 1 | 1987 | 9 |
Why?
| Blotting, Western | 2 | 1998 | 275 |
Why?
| Health Behavior | 1 | 2008 | 61 |
Why?
| Lymphocytes | 1 | 1988 | 142 |
Why?
| Signal Transduction | 1 | 1996 | 313 |
Why?
| Vaccines, Acellular | 1 | 2006 | 3 |
Why?
| Transfection | 2 | 1999 | 237 |
Why?
| Flow Cytometry | 2 | 1999 | 216 |
Why?
| Sex Factors | 1 | 2008 | 284 |
Why?
| Alanine Transaminase | 1 | 2006 | 20 |
Why?
| Mice, Knockout | 1 | 2009 | 265 |
Why?
| Pregnancy | 1 | 2011 | 455 |
Why?
| Hepatitis A Vaccines | 1 | 2005 | 3 |
Why?
| Phylogeny | 2 | 1995 | 63 |
Why?
| Personality Inventory | 1 | 2006 | 52 |
Why?
| Hepatocytes | 1 | 2006 | 42 |
Why?
| Algorithms | 1 | 2009 | 226 |
Why?
| Fatal Outcome | 1 | 2005 | 86 |
Why?
| Killer Cells, Natural | 1 | 2006 | 62 |
Why?
| Seroepidemiologic Studies | 1 | 2004 | 12 |
Why?
| Glycerol | 1 | 2005 | 24 |
Why?
| Injections, Intradermal | 1 | 2004 | 15 |
Why?
| Ethers | 1 | 2005 | 16 |
Why?
| Drug Carriers | 1 | 2005 | 17 |
Why?
| Th1 Cells | 1 | 2005 | 33 |
Why?
| Polysaccharides | 1 | 2005 | 28 |
Why?
| Headache | 1 | 2005 | 39 |
Why?
| Lipid Bilayers | 1 | 2005 | 16 |
Why?
| Blister | 1 | 2004 | 6 |
Why?
| Lipids | 1 | 2005 | 97 |
Why?
| Virus Cultivation | 1 | 2003 | 24 |
Why?
| Respiratory Therapy | 1 | 2003 | 7 |
Why?
| Rimantadine | 1 | 2003 | 7 |
Why?
| Nebulizers and Vaporizers | 1 | 2003 | 11 |
Why?
| Psychiatric Status Rating Scales | 1 | 2004 | 99 |
Why?
| Mice, Transgenic | 1 | 2006 | 209 |
Why?
| Reproducibility of Results | 1 | 2006 | 391 |
Why?
| Endocrine System | 1 | 2002 | 9 |
Why?
| Dehydroepiandrosterone | 1 | 2002 | 16 |
Why?
| Spouses | 1 | 2002 | 15 |
Why?
| Gastrointestinal Diseases | 1 | 2002 | 31 |
Why?
| Morbidity | 1 | 2002 | 62 |
Why?
| Prevalence | 1 | 2004 | 281 |
Why?
| Drug Stability | 1 | 2002 | 32 |
Why?
| Respiratory Tract Diseases | 1 | 2002 | 34 |
Why?
| Drug Therapy, Combination | 1 | 2003 | 189 |
Why?
| Octanoic Acids | 1 | 2001 | 3 |
Why?
| TRPV Cation Channels | 1 | 2001 | 4 |
Why?
| Fluorocarbons | 1 | 2001 | 5 |
Why?
| Protein Structure, Quaternary | 1 | 2001 | 18 |
Why?
| Precipitin Tests | 1 | 2001 | 81 |
Why?
| Protons | 1 | 2001 | 30 |
Why?
| Transmembrane Activator and CAML Interactor Protein | 1 | 2000 | 2 |
Why?
| Luminescent Proteins | 1 | 2001 | 67 |
Why?
| COS Cells | 1 | 2001 | 73 |
Why?
| B-Cell Activating Factor | 1 | 2000 | 8 |
Why?
| Dimerization | 1 | 2001 | 92 |
Why?
| Transglutaminases | 1 | 2001 | 12 |
Why?
| Hepatitis B Surface Antigens | 1 | 1999 | 7 |
Why?
| Hepatitis B Antibodies | 1 | 1999 | 11 |
Why?
| Green Fluorescent Proteins | 1 | 2001 | 105 |
Why?
| Amyloid Precursor Protein Secretases | 1 | 1999 | 11 |
Why?
| Burkitt Lymphoma | 1 | 2000 | 36 |
Why?
| Golgi Apparatus | 1 | 1999 | 26 |
Why?
| Endosomes | 1 | 1999 | 16 |
Why?
| Oligonucleotides, Antisense | 1 | 1999 | 46 |
Why?
| Logistic Models | 1 | 2002 | 251 |
Why?
| Area Under Curve | 1 | 1999 | 47 |
Why?
| Protease Inhibitors | 1 | 1999 | 39 |
Why?
| Amino Acid Motifs | 1 | 1999 | 52 |
Why?
| Analysis of Variance | 1 | 2002 | 339 |
Why?
| Endopeptidases | 1 | 1999 | 46 |
Why?
| Sequence Homology, Amino Acid | 1 | 2000 | 156 |
Why?
| Fluorescent Antibody Technique | 1 | 2000 | 164 |
Why?
| Plasmids | 1 | 2001 | 122 |
Why?
| Lymphoma, B-Cell | 1 | 2000 | 33 |
Why?
| Mitogens | 1 | 1999 | 31 |
Why?
| HIV Envelope Protein gp120 | 1 | 1999 | 15 |
Why?
| Macaca mulatta | 1 | 2000 | 71 |
Why?
| Staining and Labeling | 1 | 1999 | 101 |
Why?
| Choline O-Acetyltransferase | 1 | 1998 | 11 |
Why?
| Viremia | 1 | 1998 | 18 |
Why?
| Animals, Suckling | 1 | 1998 | 6 |
Why?
| Ear Diseases | 1 | 1997 | 8 |
Why?
| Hydrogen-Ion Concentration | 1 | 1999 | 176 |
Why?
| AIDS-Related Opportunistic Infections | 1 | 1998 | 41 |
Why?
| Pressure | 1 | 1997 | 79 |
Why?
| Peptides | 1 | 1999 | 154 |
Why?
| Administration, Inhalation | 1 | 1997 | 60 |
Why?
| Binding Sites | 1 | 1999 | 213 |
Why?
| DNA-Directed RNA Polymerases | 1 | 1997 | 21 |
Why?
| Controlled Clinical Trials as Topic | 1 | 1996 | 13 |
Why?
| Radioimmunoassay | 2 | 1986 | 81 |
Why?
| Dopamine | 1 | 1998 | 62 |
Why?
| Conserved Sequence | 1 | 1997 | 73 |
Why?
| Otitis Media | 1 | 1998 | 34 |
Why?
| Great Britain | 1 | 1995 | 49 |
Why?
| Rats, Sprague-Dawley | 1 | 1998 | 257 |
Why?
| Sensitivity and Specificity | 1 | 1995 | 427 |
Why?
| Viruses | 1 | 1992 | 15 |
Why?
| RNA, Messenger | 1 | 1999 | 394 |
Why?
| Brain | 1 | 1999 | 305 |
Why?
| Cross Infection | 1 | 1992 | 46 |
Why?
| Mamastrovirus | 1 | 1987 | 1 |
Why?
| Centrifugation, Density Gradient | 1 | 1986 | 48 |
Why?
| Viral Structural Proteins | 1 | 1986 | 6 |
Why?
| Molecular Weight | 1 | 1986 | 154 |
Why?
|
|
Treanor's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
